Establishment Labs Holdings Inc. (NASDAQ:ESTA) Position Lessened by RTW Investments LP

RTW Investments LP reduced its position in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA - Free Report) by 2.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,569,687 shares of the company's stock after selling 76,016 shares during the period. Establishment Labs comprises approximately 1.8% of RTW Investments LP's portfolio, making the stock its 23rd largest position. RTW Investments LP owned approximately 9.18% of Establishment Labs worth $118,385,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Redmile Group LLC boosted its holdings in Establishment Labs by 22.3% in the fourth quarter. Redmile Group LLC now owns 320,149 shares of the company's stock valued at $14,749,000 after purchasing an additional 58,346 shares in the last quarter. Nuveen Asset Management LLC raised its holdings in Establishment Labs by 13.3% during the fourth quarter. Nuveen Asset Management LLC now owns 361,515 shares of the company's stock worth $16,655,000 after purchasing an additional 42,413 shares in the last quarter. Mudita Advisors LLP raised its stake in shares of Establishment Labs by 16.8% during the 4th quarter. Mudita Advisors LLP now owns 414,500 shares of the company's stock worth $19,096,000 after buying an additional 59,699 shares in the last quarter. Millennium Management LLC raised its stake in shares of Establishment Labs by 96.9% during the 4th quarter. Millennium Management LLC now owns 711,691 shares of the company's stock worth $32,788,000 after buying an additional 350,213 shares in the last quarter. Finally, LMR Partners LLP grew its stake in shares of Establishment Labs by 130.4% during the 4th quarter. LMR Partners LLP now owns 23,037 shares of the company's stock worth $1,061,000 after purchasing an additional 13,037 shares during the period. 72.91% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research firms have recently weighed in on ESTA. Stephens reaffirmed an "overweight" rating and set a $52.00 price target on shares of Establishment Labs in a research note on Thursday, March 6th. BTIG Research initiated coverage on shares of Establishment Labs in a report on Friday. They issued a "buy" rating and a $62.00 target price on the stock. Finally, Needham & Company LLC upgraded shares of Establishment Labs from a "hold" rating to a "buy" rating and set a $48.00 price objective on the stock in a report on Wednesday, May 14th. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat, Establishment Labs currently has a consensus rating of "Moderate Buy" and a consensus target price of $55.33.

Establishment Labs Stock Up 1.8%

Establishment Labs stock traded up $0.66 during midday trading on Monday, hitting $36.82. 297,902 shares of the stock were exchanged, compared to its average volume of 470,396. The company has a debt-to-equity ratio of 5.94, a current ratio of 3.62 and a quick ratio of 2.29. The company has a 50 day moving average price of $34.39 and a two-hundred day moving average price of $38.12. The firm has a market cap of $1.06 billion, a P/E ratio of -14.27 and a beta of 0.73. Establishment Labs Holdings Inc. has a 1 year low of $26.56 and a 1 year high of $58.00.

Establishment Labs (NASDAQ:ESTA - Get Free Report) last issued its earnings results on Wednesday, May 7th. The company reported ($0.70) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.83) by $0.13. The business had revenue of $41.38 million for the quarter, compared to analyst estimates of $41.15 million. Establishment Labs had a negative net margin of 46.13% and a negative return on equity of 184.55%. The company's revenue for the quarter was up 11.3% on a year-over-year basis. During the same quarter in the prior year, the business posted ($0.58) EPS. On average, sell-side analysts predict that Establishment Labs Holdings Inc. will post -2.41 earnings per share for the current fiscal year.

Establishment Labs Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.